Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patientsGaojie Liu(Sun Yat-sen Memorial Hospital), Bing Zeng(University of Electronic Science and Technology of China)Journal of Translational MedicineMay 6, 201510.1186/s12967-015-0500-6Cited by 99SaveCiteExport RISWatch citationsRelated PapersmiR-922 regulates CYLD expression and promotes the cell proliferation of human hepatocellular carcinoma|Oncology Reports|2017|15